RxDoctor Payments Data

Brandi Parker

Physician Assistant · Bremen, GANPI 1952951535

Payments from drug & device makers

$6,074in general payments, 2019–2025

Across 356 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$902
  • Pfizer$404
  • Amgen$313
  • Lilly USA, LLC$275
  • GSK$191
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$5,97598%
  • Education$992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,074 in reported general payments places this provider in the 90th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide65$80,755
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57$46,247
RexultiBrexpiprazole12$29,354
JardianceEmpagliflozin21$25,089
MounjaroTirzepatide23$23,316
EliquisApixaban18$22,801
LinzessLinaclotide26$18,982
Tresiba Flextouch U-200Insulin Degludec22$13,799
FarxigaDapagliflozin Propanediol20$13,567
Repatha SureclickEvolocumab11$13,479
Albuterol Sulfate HfaAlbuterol Sulfate69$1,844
Levothyroxine Sodium179$1,208
NovologInsulin Aspart15$1,069
ValacyclovirValacyclovir Hcl30$1,047
Bupropion XlBupropion Hcl42$776

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$902$81,82480 claims
GSKTrelegy Ellipta$191$46,24757 claims
Otsuka America Pharmaceutical, Inc.Rexulti$181$29,35412 claims
Boehringer IngelheimJardiance$19$25,08921 claims
Lilly USA, LLCMounjaro$275$23,31623 claims
PfizerEliquis$404$22,80118 claims
AbbVieLinzess$2,314$18,98226 claims
AstraZenecaFarxiga$146$13,56720 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$17$1,208179 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Bremen

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →